Equities

EKF Diagnostics Holdings PLC

EKF:LSE

EKF Diagnostics Holdings PLC

Health CareMedical Equipment and Services
  • Price (GBX)25.00
  • Today's Change0.40 / 1.63%
  • Shares traded40.80k
  • 1 Year change-4.03%
  • Beta0.2375
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year EKF Diagnostics Holdings PLC grew net income 165.39% from 2.35m to 6.24m despite declining revenues.
Gross margin49.79%
Net profit margin12.86%
Operating margin13.49%
Return on assets7.98%
Return on equity8.71%
Return on investment8.77%
More ▼

Cash flow in GBPView more

In 2024, EKF Diagnostics Holdings PLC increased its cash reserves by 85.10%, or 6.58m. The company earned 13.66m from its operations for a Cash Flow Margin of 27.21%. In addition the company used 2.66m on investing activities and also paid 4.08m in financing cash flows.
Cash flow per share0.0243
Price/Cash flow per share9.67
Book value per share0.1597
Tangible book value per share0.0956
More ▼

Balance sheet in GBPView more

EKF Diagnostics Holdings PLC uses little debt in its capital structure as supported by a debt to capital ratio of 1.52%.
Current ratio4.62
Quick ratio3.47
Total debt/total equity0.0156
Total debt/total capital0.0152
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 165.64%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)11.40
EPS (TTM) vs
TTM 1 year ago		28.33
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.